Metraipolis › archive › dc_be9edf6e2aab
Therapeutic applications of CRISPR-Cas9 gene editing — Europe PMC PMID:41476860
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41476860
- DOI
- 10.3389/fgeed.2025.1724291
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:03:22.072Z
- SHA-256 of the archived text
6cdbd63b4eb83dcff2a652e4913ede38241d6bd1c40a7959403ddf8f3ca60f51- Stable URL of this page
https://metraipolis.com/documento/dc_be9edf6e2aab
How to cite
Therapeutic applications of CRISPR-Cas9 gene editing — Europe PMC PMID:41476860 — Europe PMC (en), https://europepmc.org/article/MED/41476860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be9edf6e2aab (Metraipolis archive dc_be9edf6e2aab, sha256 6cdbd63b4eb83dcff2a652e4913ede38241d6bd1c40a7959403ddf8f3ca60f51)
BibTeX
@misc{dcbe9edf6e2aab,
title = {Therapeutic applications of CRISPR-Cas9 gene editing — Europe PMC PMID:41476860},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41476860},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be9edf6e2aab; sha256 6cdbd63b4eb83dcff2a652e4913ede38241d6bd1c40a7959403ddf8f3ca60f51},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476860. Agents can read the archived copy with the MCP tool read_document.